ProMIS Neurosciences Inc PMN

approval date, coincidental?

[Gbathat]

This blood test has Full Accreditation for “Microbiology – SARS CoV-2 Antibody Assay” by the College of Physicians and Surgeons of British Columbia’s Diagnostic Accreditation Program using Sierra SPR-32 for  Accredited BC Neuroimmunology Laboratory effective April 1, 2021.

Hmmm... just one day after the end of PMN's fiscal year

Coincidental, or by design/request?  

Why would they not want to disclose this awesome development?  Something good is brewing, imo, and they are delaying any PR announcement to make sure they are ready to launch, also imo.  It is odd that the info is just out there on the covidimmunitypassports website though. 

I'm holding 220K shares ARFXF going into what I hope will be an exciting month for us.  I plan to hold 150K until PMN310 is through Phase II, which could be a while;D But this COVID test could really make this stock the trade of the year if they get a good chunk of that $1B+ market.  glta 

[retiredcop]

Here's a question we can all.try to answer ....who actually developed the test and who owns this test ?

[Speyeder999]

....and what part did Promis's ex-Chief Physics Officer (Steven Plotkin) had in the development. Very odd that he would jump ship after 5 years just at the very moment something big is supposed to take place. Is this just me? No mention of his departure whatsoever.....very odd!

[Gbathat]

I agree that it was odd.  He is a professor and probably plenty busy. https://phas.ubc.ca/~steve/index.html My guess is the decision was made when funds were tight last year, before our new investors rode in to the rescue. I don't think Chief Physics Officer is an official leadership position, so probably no requirement to provide public notice.  Based on recent publications,

[Gbathat]

b) Joint arrangement 2 (JV2) will provide the service of highly sensitive and specific serological assays for the detection and characterization of antibodies to the SARS-CoV-2 virus that is responsible for COVID-19. JV2 includes a jointly controlled venture (Immusafe Labs, Inc.) and jointly controlled operations. The company acquired 50% of Immusafe Labs, Inc. for $3,000. The company is

[Gbathat]

And now, tying PMN (via Immusafe) to covidimmunitypassport.com , see their 'founders' page During this pandemic, the lab has supported the COVID-19 battle by performing PCR testing and, more recently, evaluating post-vaccination antibodies. Immusafe Inc was created to commercialize this test to physicians and their patients.

[DavidKingCanada]

All in all this is excellent news for Promis Neurosciences. Definitely a Buy and Hold!